FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Overview Fund Activity
Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

31 hedge funds and large institutions have $61.3M invested in Fusion Pharmaceuticals Inc. Common Shares in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 1 closing their positions.

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
2
Reduced
8
Closed
1
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$5K

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$7.78M
2
Millennium Management
2
Millennium Management
New York
$29K
3
TRCT
3
Tower Research Capital (TRC)
New York
$8K
4
HFS
4
Heritage Financial Services
Massachusetts
$2K
5
SCM
5
Sio Capital Management
New York
$649K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$2.62M
2
RSCM
2
Rock Springs Capital Management
Maryland
$2.02M
3
WP
3
Woodline Partners
California
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$146K
5
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$3.89M
Name Market Value Shares Shares
Change 		Shares
Change %
TWC
26
TD Waterhouse Canada
Ontario, Canada
$2.33K 875 – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$2K 850 – –
HFS
28
Heritage Financial Services
Massachusetts
$2K 1,000 +1,000 New
S
29
SignatureFD
Georgia
$1K 300 – –
TC
30
Truvestments Capital
Florida
$1K 335 +335 New
APA
31
American Portfolios Advisors
New York
$75 30 – –
WP
32
Woodline Partners
California
– – -25,703 Closed
Simplex Trading
33
Simplex Trading
Illinois
– – – –
Wells Fargo
34
Wells Fargo
California
– – – –
CFGS
35
Concourse Financial Group Securities
Alabama
– – – –
1
2